Pneumocystis jiroveci pneumonia in Taiwan from 2014 to 2017: Clinical manifestations and outcomes between pediatric and adult patients

Journal of Microbiology, Immunology and Infection

Volumn 52, Issue 6, 2019, Pages 983-990

  Lee, Hsin Yao ^a   Lu, Chun Yi ^a   Lee, Ping Ing ^a   Chen, Jong Min ^a   Huang, Li Min ^a   Chang, Luan Yin ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Opportunistic infection; Pediatric; Pneumocystis jiroveci pneumonia

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; CORTICOSTEROID; COTRIMOXAZOLE; METHYLPREDNISOLONE; NITRIC OXIDE; ANTIINFECTIVE AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACUTE KIDNEY FAILURE; ADULT; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; AUTOIMMUNE DISEASE; BLOODSTREAM INFECTION; BRONCHOALVEOLAR LAVAGE FLUID; CANCER CHEMOTHERAPY; CHILD; CHILDHOOD CANCER; CLINICAL FEATURE; COUGHING; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DYSPNEA; EXTRACORPOREAL OXYGENATION; FEMALE; FEVER; GASTROINTESTINAL HEMORRHAGE; HEPATITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERKALEMIA; HYPONATREMIA; IMMUNE DEFICIENCY; LUNG INFILTRATE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PNEUMOCYSTIS PNEUMONIA; PNEUMOTHORAX; POLYMERASE CHAIN REACTION; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; SYMPTOM; TAIWAN; VOMITING; ADOLESCENT; AGE; AGED; COMPARATIVE STUDY; IMMUNOCOMPROMISED PATIENT; INFANT; MEDICAL RECORD; MICROBIOLOGY; MIDDLE AGED; MORTALITY; PRESCHOOL CHILD; SPUTUM; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; INFANT; MALE; MEDICAL RECORDS; MIDDLE AGED; PNEUMONIA, PNEUMOCYSTIS; RETROSPECTIVE STUDIES; SPUTUM; TAIWAN; TREATMENT OUTCOME; YOUNG ADULT;

EID: 85066314732     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2019.05.003     Document Type: Article

References (24)

1. Stringer, J.R., Cushion, M.T., Wakefield, A.E., New nomenclature for the genus Pneumocystis. J Eukaryot Microbiol(Suppl), 2001, 184–189S.
2. Gigliotti, Francis, Wright, Terry W., Pneumocystis jiroveci. Kliegman, Robert M., Bonita, Stanton, St. Geme, Joseph, Schor, Nina F., (eds.) Nelson textbook of pediatrics edition 20, 2016, Elsevier Inc, 1536–1537.
3. Morris, A., Lundgren, J.D., Masur, H., Walzer, P.D., Hanson, D.L., Frederick, T., et al. Current epidemiology of pneumocystis pneumonia. Emerg Infect Dis 10 (2004), 1713–1720.
4. Chien, J.Y., Liu, C.J., Chuang, P.C., Lee, T.F., Huang, Y.T., Liao, C.H., et al. Evaluation of the automated Becton Dickinson MAX real-time PCR platform for detection of Pneumocystis jirovecii. Future Microbiol 12 (2017), 29–37.
5. Wong, Kin-Sun, Ngern Sae-Lom, S., Hung, Iou-Jih, Yang, Chao-Ping, Pneumocystis jiroveci pneumonia in non-HIV immunocompromised Taiwanese children. World J Pediatr 3 (2007), 200–202.
6. Kim, K.R., Kim, J.M., Kang, J.M., Kim, Y.J., Pneumocystis jirovecii pneumonia in pediatric patients: an analysis of 15 confirmed consecutive cases during 14 years. Kor J Pediatr 59 (2016), 252–255.
7. Baden, L.R., Swaminathan, S., Angarone, M., Blouin, G., Camins, B.C., Casper, C., et al. Prevention and treatment of cancer-related infections, version 2.2016, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 14 (2016), 882–913.
8. Stern, A., Green, H., Paul, M., Vidal, L., Leibovici, L., Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients. Cochrane Database Syst Rev(10), 2014, CD00590.
9. Lighter-Fisher, J., Stanley, K., Phillips, M., Pham, V., Klejmont, L.M., Preventing infections in children with cancer. Pediatr Rev 37 (2016), 247–258.
10. Neumann, S., Krause, S.W., Maschmeyer, G., Schiel, X., von Lilienfeld-Toal, M., Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematological malignancies and solid tumors. Ann Hematol 92 (2013), 433–442.
11. Lee, P.H., Fu, P.K., Coinfection of Pneumocystis jiroveci pneumonia and pulmonary aspergillosis in a non-HIV-infected patient. J Microbiol Immunol Infect 51 (2018), 860–861.
12. Proudfoot, R., Phillips, B., Wilne, S., Guidelines for the prophylaxis of Pneumocystis jirovecii pneumonia (PJP) in children with solid tumors. J Pediatr Hematol Oncol 39 (2017), 194–202.
13. Tomblyn, M., Chiller, T., Einsele, H., Gress, R., Sepkowitz, K., Storek, J., et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant 15 (2009), 1143–1238.
14. Liebling, M., Rubio, E., Ie, S., Prophylaxis for Pneumocystis jiroveci pneumonia: is it a necessity in pulmonary patients on high-dose, chronic corticosteroid therapy without AIDS?. Expert Rev Respir Med 9 (2015), 171–181.
15. Green, H., Paul, M., Vidal, L., Leibovici, L., Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials. Mayo Clin Proc 82 (2007), 1052–1059.
16. Sepkowitz, K.A., Brown, A.E., Armstrong, D., Pneumocystis carinii pneumonia without acquired immunodeficiency syndrome. More patients, same risk. Arch Intern Med 155 (1995), 1125–1128.
17. Gebistorf, F., Karam, O., Wetterslev, J., Afshari, A., Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) in children and adults. Cochrane Database Syst Rev(6), 2016, CD002787.
18. Kim, S.J., Lee, J., Cho, Y.J., Park, Y.S., Lee, C.H., Yoon, H., Prognostic factors of Pneumocystis jirovecii pneumonia in patients without HIV infection. J Infect 69 (2014), 88–95.
19. Li, M.C., Lee, N.Y., Lee, C.C., Lee, H.C., Chang, C.M., Ko, W.C., Pneumocystis jiroveci pneumonia in immunocompromised patients: delayed diagnosis and poor outcomes in non-HIV-infected individuals. J Microbiol Immunol Infect 47 (2014), 42–47.
20. Bienvenu, A.L., Traore, K., Plekhanova, I., Bouchrik, M., Bossard, C., Picot, S., Pneumocystis pneumonia suspected cases in 604 non-HIV and HIV patients. Int J Infect Dis 46 (2016), 11–17.
21. Morris, A., Norris, K.A., Colonization by Pneumocystis jirovecii and its role in disease. Clin Microbiol Rev 25 (2012), 297–317.
22. Thomas, C.F. Jr., Limper, A.H., Limper. Pneumocystis pneumonia. N Engl J Med 350 (2004), 2487–2498.
23. Yu, Q., Jia, P., Su, L., Zhao, H., Que, C., Outcomes and prognostic factors of non-HIV patients with Pneumocystis jirovecii pneumonia and pulmonary CMV co-infection: a retrospective cohort study. BMC Infect Dis, 17, 2017, 392.
24. Kim, T., Moon, S.M., Sung, H., Kim, M.N., Kim, S.H., Choi, S.H., et al. Outcomes of non-HIV-infected patients with Pneumocystis pneumonia and concomitant pulmonary cytomegalovirus infection. Scand J Infect Dis 44 (2012), 670–677.